Cynapsus Therapeutics (CYNA) Priced

Developing an easier-to-use formulation of apomorphine for Parkinson's disease.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $40.48 +0.00 (+0.0%)
First Day Return 4.6%
Return from IPO 189.1%
 
Cynapsus Therapeutics IPO News more
  • .
IPO Data
IPO File Date 05/15/2015
Offer Price $14.00
Price Range $14.60 - $14.60
Offer Shares (mm) 4.5
Deal Size ($mm) 63
 
IPO Data
IPO Date 06/17/2015
Offer Price $14.00
Price Range $14.60 - $14.60
Offer Shares (mm) 4.5
Deal Size ($mm) $63
 
Underwriters
more
Business Overview
Developing an easier-to-use formulation of apomorphine for Parkinson's disease.
Developing an easier-to-use formulation of apomorphine for Parkinson's disease.
more
Company Data
Headquarters Toronto, , Canada
Founded 2004
Employees 17
Website www.cynapsustherapeutics.com
 

Performance vs. IPO Index (IPOUSA)